CCC
CVS icon

Crescent Capital Consulting’s CVS Health CVS Stock Holding History

Crescent Capital Consulting’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$180K Hold
1,739
– – 0.03% 189
2021
Q3 		$147K Hold
1,739
– – 0.03% 202
2021
Q2 		$145K Sell
1,739
-317
-15% -$26K 0.03% 200
2021
Q1 		$155K Buy
2,056
+17
+0.8% +$1.24K 0.03% 198
2020
Q4 		$139K Buy
+2,039
New +$133K 0.04% 184

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Crescent Capital Consulting's CVS Position: Q4 2021 in Review

Crescent Capital Consulting held its CVS Health (CVS) position steady in Q4 2021 at 1,739 shares worth $180K. The position accounts for 0.03% of the portfolio, ranked #189.

Crescent Capital Consulting first reported a position in CVS in Q4 2020 and has held it in 5 quarters since. 2,342 funds tracked by Wall St. Rank hold CVS as of Q4 2021.

  • Crescent Capital Consulting held 1,739 shares of CVS Health worth $180K as of Q4 2021.
  • Crescent Capital Consulting left its CVS Health share count unchanged in Q4 2021.
  • CVS Health made up 0.03% of Crescent Capital Consulting's portfolio in Q4 2021, its #189 holding.
  • Crescent Capital Consulting first reported a position in CVS Health in Q4 2020 and has held it in 5 quarters since.
  • 2,342 funds tracked by Wall St. Rank held CVS Health as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.